News
MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...
Q2 2025 Earnings Call Transcript August 12, 2025 Altimmune, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.32. Operator: Good morning, ladies and gentlemen, and ...
TipRanks on MSN18h
Altimmune Reports Promising Trial Results and Financial Growth
Altimmune ( ($ALT) ) has released its Q2 earnings. Here is a breakdown of the information Altimmune presented to its investors. Altimmune, Inc. is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback